跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 63,148 条关于
“MSI-high solid tumors”
全部
63,148
临床试验
43,391
药物
1,250
机构
349
资讯
18,158
去年
IDEAYA Biosciences' Werner Helicase Inhibitor IDE275 Cleared for Phase 1 Trial in MSI-High Solid Tumors
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
去年
FDA Approves MI Cancer Seek as Companion Diagnostic for Targeted Therapy Across Tumor Types
去年
IDEAYA Biosciences Announces Strategic Updates and 2025 Corporate Guidance
11个月前
Invikafusp Alfa Shows Promise in Checkpoint Inhibitor-Resistant Solid Tumors with High Disease Control Rates
去年
NGS Demonstrates High Concordance with IHC for MSI Assessment in Solid Tumors
去年
Nimbus Therapeutics Initiates First-in-Human Trial of NDI-219216 for MSI-H Tumors Resistant to Standard Therapies
去年
MOMA Therapeutics Initiates First-in-Human Trial of Werner Helicase Inhibitor MOMA-341 for MSI-H Solid Tumors
5年前
Controversy Surrounds FDA Approval of Pembrolizumab for High TMB Solid Tumors
第 1 页,共 1816 页
上一页
下一页